{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:28:19Z","timestamp":1791822499160,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T00:00:00Z","timestamp":1667001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jacc.2022.10.016","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T13:50:24Z","timestamp":1667310624000},"page":"237-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Comparison of Drug-Coated Balloons vs Bare-Metal Stents in Patients With Femoropopliteal Arterial Disease"],"prefix":"10.1016","volume":"81","author":[{"given":"Mehdi H.","family":"Shishehbor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dierk","family":"Scheinert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashit","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Brodmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Tepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Laird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna J.","family":"Rocha-Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2704-3871","authenticated-orcid":false,"given":"Thomas","family":"Zeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2022.10.016_bib1","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.jcin.2016.06.055","article-title":"Acotec drug-coated balloon catheter: randomized, multicenter, controlled clinical study in femoropopliteal arteries: evidence from the AcoArt I Trial","volume":"9","author":"Jia","year":"2016","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2022.10.016_bib2","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/CIRCULATIONAHA.117.028893","article-title":"Stellarex drug-coated balloon for treatment of femoropopliteal disease: twelve-month outcomes from the randomized ILLUMENATE pivotal and pharmacokinetic studies","volume":"136","author":"Krishnan","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.10.016_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007702","article-title":"Long-term clinical effectiveness of a drug-coated balloon for the treatment of femoropopliteal lesions","volume":"12","author":"Laird","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2022.10.016_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.10.016_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1526602814564383","article-title":"Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX P-I randomized trial","volume":"22","author":"Scheinert","year":"2015","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jacc.2022.10.016_bib6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00270-012-0492-z","article-title":"Randomized trial of the SMART stent versus balloon angioplasty in long superficial femoral artery lesions: the SUPER study","volume":"36","author":"Chalmers","year":"2013","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jacc.2022.10.016_bib7","first-page":"1090","article-title":"Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions","volume":"74","author":"Dick","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2022.10.016_bib8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/CIRCULATIONAHA.107.689141","article-title":"Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10\u00a0cm in length: the femoral artery stenting trial (FAST)","volume":"116","author":"Krankenberg","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.10.016_bib9","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1161\/CIRCULATIONAHA.107.688341","article-title":"Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting","volume":"115","author":"Schillinger","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.10.016_bib10","first-page":"1168","article-title":"Angiographic characteristics of femoropopliteal in-stent restenosis: association with long-term outcomes after endovascular intervention","volume":"82","author":"Armstrong","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2022.10.016_bib11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.10.016_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005891","article-title":"Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN.PACT SFA randomized trial","volume":"11","author":"Schneider","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2022.10.016_bib13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/1526602817745565","article-title":"Drug-coated balloon vs standard percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal arteries: one-year results of the MDT-2113 SFA Japan randomized trial","volume":"25","author":"Iida","year":"2018","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jacc.2022.10.016_bib14","first-page":"664","article-title":"Drug-coated balloon versus uncoated percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal artery: 2-year results of the MDT-2113 SFA Japan randomized trial","volume":"93","author":"Iida","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2022.10.016_bib15","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1177\/1526602820948240","article-title":"Three-year results of the IN.PACT SFA Japan trial comparing drug-coated balloons with percutaneous transluminal angioplasty","volume":"27","author":"Soga","year":"2020","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jacc.2022.10.016_bib16","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1583\/13-4548R.1","article-title":"Nitinol stent implantation in the superficial femoral artery and proximal popliteal artery: twelve-month results from the complete SE multicenter trial","volume":"21","author":"Laird","year":"2014","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jacc.2022.10.016_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jvs.2012.12.066","article-title":"The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protege EverfLex NitInol STent SYstem II (DURABILITY II)","volume":"58","author":"Matsumura","year":"2013","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jacc.2022.10.016_bib18","first-page":"164","article-title":"A\u00a0single stent strategy in patients with lifestyle limiting claudication: 3-year results from the Durability II trial","volume":"86","author":"Rocha-Singh","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2022.10.016_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.avsg.2013.05.006","article-title":"The impact of sex on angioplasty and primary stenting for femoropopliteal occlusive disease: results of the DURABILITY II trial","volume":"28","author":"Tadros","year":"2014","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jacc.2022.10.016_bib20","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"key":"10.1016\/j.jacc.2022.10.016_bib21","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/sim.5984","article-title":"The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments","volume":"33","author":"Austin","year":"2014","journal-title":"Stat Med"},{"key":"10.1016\/j.jacc.2022.10.016_bib22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ckj\/sfab158","article-title":"An introduction to inverse probability of treatment weighting in observational research","volume":"15","author":"Chesnaye","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.jacc.2022.10.016_bib23","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1002\/sim.8206","article-title":"Adjusted restricted mean survival times in observational studies","volume":"38","author":"Conner","year":"2019","journal-title":"Stat Med"},{"key":"10.1016\/j.jacc.2022.10.016_bib24","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1161\/CIRCRESAHA.121.318261","article-title":"Advances in revascularization for peripheral artery disease: revascularization in PAD","volume":"128","author":"Beckman","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2022.10.016_bib25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1148\/radiol.2241011253","article-title":"Inflammatory response to stent implantation: differences in femoropopliteal, iliac, and carotid arteries","volume":"224","author":"Schillinger","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.jacc.2022.10.016_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/152660280200900111","article-title":"Balloon angioplasty and stent implantation induce a vascular inflammatory reaction","volume":"9","author":"Schillinger","year":"2002","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jacc.2022.10.016_bib27","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jacc.2004.11.026","article-title":"Prevalence and clinical impact of stent fractures after femoropopliteal stenting","volume":"45","author":"Scheinert","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.10.016_bib28","first-page":"149","article-title":"Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery - focus on the paclitaxel eluting stent","volume":"7","author":"Litsky","year":"2014","journal-title":"Med Devices (Auckl)"},{"key":"10.1016\/j.jacc.2022.10.016_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40256-013-0023-6","article-title":"Endovascular stents: a review of their use in peripheral arterial disease","volume":"13","author":"Kudagi","year":"2013","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jacc.2022.10.016_bib30","first-page":"549","article-title":"Directional atherectomy before paclitaxel coated balloon angioplasty in complex femoropopliteal disease: The VIVA REALITY study","volume":"98","author":"Rocha-Singh","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2022.10.016_bib31","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1586\/14779072.2013.837758","article-title":"Drug-coated balloons in interventional cardiology","volume":"11","author":"Giannini","year":"2013","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.jacc.2022.10.016_bib32","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jvs.2017.06.112","article-title":"Cost-effectiveness analysis of drug-coated therapies in the superficial femoral artery","volume":"67","author":"Sridharan","year":"2018","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jacc.2022.10.016_bib33","unstructured":"U.S. Food and Drug Administration. Summary of safety and effectiveness data, everflex self-expanding peripheral stent system (P110023b). Accessed August 26, 2022. https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf11\/P110023b.pdf"},{"key":"10.1016\/j.jacc.2022.10.016_bib34","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.jvir.2017.08.003","article-title":"Endovascular interventions for femoropopliteal peripheral artery disease: a network meta-analysis of current technologies","volume":"28","author":"Jaff","year":"2017","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jacc.2022.10.016_bib35","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1016\/j.ijcard.2013.06.081","article-title":"Paclitaxel-coated balloon or primary bare nitinol stent for revascularization of femoropopliteal artery: a meta-analysis of randomized trials versus uncoated balloon and an adjusted indirect comparison","volume":"168","author":"Fusaro","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2022.10.016_bib36","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.jvs.2020.10.075","article-title":"Network meta-analysis of drug-coated balloon angioplasty versus primary nitinol stenting for femoropopliteal atherosclerotic disease","volume":"73","author":"Abdoli","year":"2021","journal-title":"J\u00a0Vasc Surg"},{"issue":"6","key":"10.1016\/j.jacc.2022.10.016_bib37","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1177\/15266028211068772","article-title":"A\u00a0single-center study on the outcomes of target limb revascularization in femoropopliteal lesions treated with drug coated balloons and bare metal stents","volume":"29","author":"Linehan","year":"2022","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jacc.2022.10.016_bib38","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.avsg.2021.09.022","article-title":"Mid-term efficacy and safety of drug-coated balloon versus nitinol bare metal stent for primary lesions in femoropopliteal artery disease","volume":"81","author":"Ma","year":"2022","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jacc.2022.10.016_bib39","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.avsg.2021.01.079","article-title":"Drug-coated balloon versus bare nitinol stent in femoropopliteal artery: 12\u00a0months outcome from a single center in China","volume":"74","author":"Zhao","year":"2021","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jacc.2022.10.016_bib40","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/1526602816628285","article-title":"Midterm patency after femoropopliteal interventions: a comparison of standard and interwoven nitinol stents and drug-coated balloons in a single-center, propensity score-matched analysis","volume":"23","author":"Steiner","year":"2016","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jacc.2022.10.016_bib41","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.avsg.2022.03.031","article-title":"A\u00a0systematic review aggregated data and individual participant data meta-analysis of spot stenting in the treatment of lower extremity peripheral arterial disease","volume":"85","author":"Bontinis","year":"2022","journal-title":"Ann Vasc Surg"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109722071613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109722071613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:55:32Z","timestamp":1760018132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109722071613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0735109722071613"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2022.10.016","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Drug-Coated Balloons vs Bare-Metal Stents in Patients With Femoropopliteal Arterial Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2022.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}